Latest news, press releases, and SEC filings for Relmada Therapeutics Inc (RLMD) https://caymanjournal.com/stock/RLMD en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 21:45:10 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a **preliminary proxy statement** (PRE 14A) for Relmada Therapeutics. Its main purpose is to tell shareholders about the company's annual meeting and give them the information they need to vote on important proposals. 👉 **Why it matters:** As a shareholder, this https://caymanjournal.com/stock/RLMD/sec-filing/0001213900-26-040498 https://caymanjournal.com/stock/RLMD/sec-filing/0001213900-26-040498 Mon, 06 Apr 2026 00:00:00 GMT SEC Filing